Today, the President & CEO of Vermillion (NASDAQ: VRML), Valerie Barber Palmieri, bought shares of VRML for $9,741.
Following this transaction Valerie Barber Palmieri’s holding in the company was increased by 30.82% to a total of $40.53K. In addition to Valerie Barber Palmieri, one other VRML executive reported Buy trades in the last month.
See today’s analyst top recommended stocks >>
Currently, Vermillion has an average volume of 358.7K.
Starting in February 2015, VRML received 19 Buy ratings in a row.
The insider sentiment on Vermillion has been positive according to 18 insider trades in the past three months. This sentiment is slightly higher than the average sentiment of company insiders in this sector.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Vermillion, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. The company’s bio-analytical solutions helps physicians diagnose, treat and improve gynecologic health outcomes for women.
